Volume 3, Issue 1, March 2021, Pages 7 - 9
Dexamethasone as a Treatment of COVID-19
Abdullah Alkattan1, 2, *, , Mahmoud Kandeel1, 3, *
1Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa, Saudi Arabia
2Chronic Disease Prevention Center, Ministry of Health, Riyadh, Saudi Arabia
3Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh, Egypt
Abdullah Alkattan, Mahmoud Kandeel
Received 5 October 2020, Accepted 14 November 2020, Available Online 3 December 2020.
- https://doi.org/10.2991/dsahmj.k.201125.001How to use a DOI?
- COVID-19; SARS-CoV-2; cytokine storm; dexamethasone
- © 2020 Dr. Sulaiman Al Habib Medical Group. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - JOUR AU - Abdullah Alkattan AU - Mahmoud Kandeel PY - 2020 DA - 2020/12/03 TI - Dexamethasone as a Treatment of COVID-19 JO - Dr. Sulaiman Al Habib Medical Journal SP - 7 EP - 9 VL - 3 IS - 1 SN - 2590-3349 UR - https://doi.org/10.2991/dsahmj.k.201125.001 DO - https://doi.org/10.2991/dsahmj.k.201125.001 ID - Alkattan2020 ER -